Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Review of 2008: Economy weakens, investors baulk, IPOs fall by the wayside

This article was originally published in Clinica

Executive Summary

One year ago, when New Stock Tracker looked back over the medtech IPOs of 2007, the sub-prime mortgage crisis and the subsequent economic downturn had just started to wreak havoc with companies' chances of going public. Now, with the credit crunch in full effect, 2007 is looking reasonably prosperous compared to 2008, a year in which medtech firms struggled to reach even flotation, let alone provide investors with a significant return. Indeed, 2008 was a year to forget for IPOs in general, not just in the medical device sector.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT041633

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel